Showing results (291-300 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 19, 2000
Reversal of drug resistance in sarcoma-45 by the new calmodulin antagonist--trihydrochloride of [1,2,5-trimethyl-4-phenyl-4-beta-[N-(beta-ethylamino)-N-4'-methoxybe nzy l]-ethylamino] piperidine (AR-2)A R Alexanian, N S ArutyunianInvestigational New Drugs|January 19, 2000
Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapyC J Dimitroff, W Klohs, A Sharma, et al.Investigational New Drugs|January 19, 2000
Ethical issues in the development of new agentsC K DaughertyInvestigational New Drugs|January 19, 2000
A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancerR S Witte, S Lipsitz, T L Goodman, et al.Investigational New Drugs|January 19, 2000
Phase II clinical trial of didemnin B in patients with recurrent or refractory anaplastic astrocytoma or glioblastoma multiforme (NSC 325319)A Mittelman, H G Chun, C Puccio, et al.Investigational New Drugs|January 19, 2000
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combinationJ E Romaguera, M A Rodriguez, F B Hagemeister, et al.Investigational New Drugs|November 11, 1999
Activity and DNA binding of new organoamidoplatinum (II) complexesT Talarico, D R Phillips, G B Deacon, et al.Investigational New Drugs|November 11, 1999
Leucovorin, 5-fluorouracil, and gemcitabine: a phase I studyE Poplin, J Roberts, M Tombs, et al.Investigational New Drugs|June 8, 2001
Determinants of paclitaxel uptake, accumulation and retention in solid tumorsS H Jang, M G Wientjes, J L AuInvestigational New Drugs|June 8, 2001
Oral delivery of taxanesM M Malingré, J H Beijnen, J H SchellensPageof 372